SDC1 and plasma cell myeloma: Interestingly, recent insights into the effects of heparanase-induced shedding of syndecan-1, an HSPG implicated in the pathobiology of multiple myeloma, revealed a unifying mechanism whereby heparanase expression promotes different aspects of disease progression [92].